ArticleActa pharmacologica Sinica2025

IMPDH inhibitors upregulate PD-L1 in cancer cells without impairing immune checkpoint inhibitor efficacy.

Ming-Ming Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.